News
-
-
PRESS RELEASE
Pyrum reaches next milestone: Plant purchase agreement signed for joint venture facility in the Czech Republic
Pyrum Innovations AG signs plant purchase agreement for joint venture facility in the Czech Republic, marking a significant milestone in the international rollout of Pyrum's technology -
PRESS RELEASE
adesso SE reports dynamic sales growth of 13% and a disproportionately high increase in EBITDA of 21% for the first half of the year / Full-year forecast confirmed
adesso SE reports 13% sales growth and 21% EBITDA increase in H1 2026. Full-year forecast confirmed. GenAI drives growth in cloud transformation and AI -
PRESS RELEASE
SFC Energy achieves record first half with a strong increase in profitability – Forecast 2026 narrowed on the upside
SFC Energy AG achieves record first half with a strong increase in profitability. Forecast for 2026 narrowed on the upside, highlighting growth and strategic positioning -
-
PRESS RELEASE
NORMA Group launches second public share buyback offer with a total volume of approximately EUR 208 million
NORMA Group launches second public share buyback offer totaling approximately EUR 208 million. Offer price at EUR 22.35 per share includes a 25.47% premium. Company aims to complete capital return to shareholders -
PRESS RELEASE
EQS-Adhoc: NORMA Group SE: Management Board initiates public share buyback offer with a volume of approximately EUR 208 million for up to a total of 9,306,487 shares
NORMA Group SE Management Board initiates public share buyback offer of approximately EUR 208 million for up to 9,306,487 shares, following the resolution at the Annual General Meeting -
-
PRESS RELEASE
Pfizer and Valneva’s Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency
European Medicines Agency validates Pfizer and Valneva's MAA for Lyme Disease Vaccine Candidate based on Phase 3 results. Potential game-changer in Lyme disease prevention -
![Logo of [UNKNOWN]](https://logos.symex.be/img/.jpg)
